HC Wainwright Begins Coverage on Agios Pharmaceuticals (NASDAQ:AGIO)
HC Wainwright assumed coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research note published on Monday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $58.00 target price on the biopharmaceutical company’s stock. A number of other research analysts have also issued reports on the stock. StockNews.com lowered […]
HC Wainwright assumed coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research note published on Monday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $58.00 target price on the biopharmaceutical company’s stock. A number of other research analysts have also issued reports on the stock. StockNews.com lowered […]
